Tags

Type your tag names separated by a space and hit enter

High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
J Clin Microbiol. 2020 10 21; 58(11)JC

Authors+Show Affiliations

AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France narjis.boukli@aphp.fr.AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France.AP-HP, Centre Hospitalo-Universitaire Trousseau, Laboratoire de Virologie, Paris, France. Sorbonne Universités, Paris, France. INSERM, UMR_S 938, Centre de Recherche Saint-Antoine Metabolic and Biliary, Fibro-inflammatory Diseases of the Liver, Paris, France.AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France.AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France.AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France. Sorbonne Universités, Paris, France. INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.AP-HP, Centre Hospitalo-Universitaire Saint-Antoine, Laboratoire de Virologie, Paris, France. Sorbonne Universités, Paris, France. INSERM, UMR_S 938, Centre de Recherche Saint-Antoine Cancer Biology and Therapeutics, Paris, France.

Pub Type(s)

Evaluation Study
Letter

Language

eng

PubMed ID

32848041

Citation

Boukli, Narjis, et al. "High Incidence of False-Positive Results in Patients With Acute Infections Other Than COVID-19 By the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies." Journal of Clinical Microbiology, vol. 58, no. 11, 2020.
Boukli N, Le Mene M, Schnuriger A, et al. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. J Clin Microbiol. 2020;58(11).
Boukli, N., Le Mene, M., Schnuriger, A., Cuervo, N. S., Laroche, C., Morand-Joubert, L., & Gozlan, J. (2020). High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. Journal of Clinical Microbiology, 58(11). https://doi.org/10.1128/JCM.01352-20
Boukli N, et al. High Incidence of False-Positive Results in Patients With Acute Infections Other Than COVID-19 By the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. J Clin Microbiol. 2020 10 21;58(11) PubMed PMID: 32848041.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies. AU - Boukli,Narjis, AU - Le Mene,Melchior, AU - Schnuriger,Aurélie, AU - Cuervo,Nancy Stella, AU - Laroche,Cécilia, AU - Morand-Joubert,Laurence, AU - Gozlan,Joël, Y1 - 2020/10/21/ PY - 2020/8/28/pubmed PY - 2020/11/5/medline PY - 2020/8/28/entrez KW - COVID-19 KW - SARS-CoV-2 KW - antibodies KW - coronavirus KW - serological tests JF - Journal of clinical microbiology JO - J Clin Microbiol VL - 58 IS - 11 SN - 1098-660X UR - https://www.unboundmedicine.com/medline/citation/32848041/High_Incidence_of_False_Positive_Results_in_Patients_with_Acute_Infections_Other_than_COVID_19_by_the_Liaison_SARS_CoV_2_Commercial_Chemiluminescent_Microparticle_Immunoassay_for_Detection_of_IgG_Anti_SARS_CoV_2_Antibodies_ L2 - http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=32848041 DB - PRIME DP - Unbound Medicine ER -